Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Front Digit Health ; 5: 1187578, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37621964

RESUMO

Introduction: In gynecologic oncology, ovarian cancer is a great clinical challenge. Because of the lack of typical symptoms and effective biomarkers for noninvasive screening, most patients develop advanced-stage ovarian cancer by the time of diagnosis. MicroRNAs (miRNAs) are a type of non-coding RNA molecule that has been linked to human cancers. Specifying diagnostic biomarkers to determine non-cancer and cancer samples is difficult. Methods: By using Boruta, a novel random forest-based feature selection in the machine-learning techniques, we aimed to identify biomarkers associated with ovarian cancer using cancerous and non-cancer samples from the Gene Expression Omnibus (GEO) database: GSE106817. In this study, we used two independent GEO data sets as external validation, including GSE113486 and GSE113740. We utilized five state-of-the-art machine-learning algorithms for classification: logistic regression, random forest, decision trees, artificial neural networks, and XGBoost. Results: Four models discovered in GSE113486 had an AUC of 100%, three in GSE113740 with AUC of over 94%, and four in GSE113486 with AUC of over 94%. We identified 10 miRNAs to distinguish ovarian cancer cases from normal controls: hsa-miR-1290, hsa-miR-1233-5p, hsa-miR-1914-5p, hsa-miR-1469, hsa-miR-4675, hsa-miR-1228-5p, hsa-miR-3184-5p, hsa-miR-6784-5p, hsa-miR-6800-5p, and hsa-miR-5100. Our findings suggest that miRNAs could be used as possible biomarkers for ovarian cancer screening, for possible intervention.

2.
IEEE/ACM Trans Comput Biol Bioinform ; 18(6): 2384-2393, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-32396098

RESUMO

Ovarian cancer is the deadliest gynecologic malignancy, mainly due to limitations in early diagnosis. With advances in high-throughput technologies, research interest in identifying novel and customized tumor biomarkers for early detection and diagnosis is rapidly growing. Here we introduce a new tool called EBST to select microRNAs with biomarker potency in ovarian cancer. This tool has pre-processing options and Its core is the use of Modified Multi Objective Imperialist Competitive Algorithm and six objective functions based on the classifier performance/structure evaluation, clustering error and mRMR filter. In this paper, we used the FDR filter in the pre-processing stage and considered five objective functions, four of which relate to the l1-SVM classifier performance and one to the average mRMR ranking. The proposed method has identified 11 microRNAs including hsa-miR-6784-5p, hsa-miR-1228-5p, hsa-miR-8073, hsa-miR-6756-5p, hsa-miR-1307-3p, hsa-miR-4697-5p, hsa-miR-3663-3p, hsa-miR-328-5p, hsa-miR-1228-3p, hsa-miR-6821-5p, hsa-miR-1268a. Data classification by the proposed model showed 100 percent sensitivity, 99.38 percent specificity, 99.69 percent accuracy and 99.39 percent positive predictive value. In comparison with routine state-of-the-art methods, superiority of our method was confirmed. The biological evaluation of selected microRNAs using bioinformatics tools and published articles confirms their role in cancer signaling pathways. The tool and its MATLAB code are freely available at https://github.com/hanif-y.


Assuntos
Biomarcadores Tumorais/genética , Biologia Computacional/métodos , MicroRNAs/genética , Neoplasias Ovarianas , Algoritmos , Feminino , Humanos , Aprendizado de Máquina , Neoplasias Ovarianas/diagnóstico , Neoplasias Ovarianas/genética , Transcriptoma
3.
J Med Signals Sens ; 2(1): 61-70, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23493097

RESUMO

Understanding the genetic regulatory networks, the discovery of interactions between genes and understanding regulatory processes in a cell at the gene level are the major goals of system biology and computational biology. Modeling gene regulatory networks and describing the actions of the cells at the molecular level are used in medicine and molecular biology applications such as metabolic pathways and drug discovery. Modeling these networks is also one of the important issues in genomic signal processing. After the advent of microarray technology, it is possible to model these networks using time-series data. In this paper, we provide an extensive review of methods that have been used on time-series data and represent the features, advantages and disadvantages of each. Also, we classify these methods according to their nature. A parallel study of these methods can lead to the discovery of new synthetic methods or improve previous methods.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...